Brief: Bio-Gene Technology Says Bio-Gene Executes Commercial Development Agreement On Flavocide Technology
04/04/2022 02:35
April 4 (Reuters) - Bio-Gene Technology Ltd BGT.AX :
* BIO-GENE EXECUTES COMMERCIAL DEVELOPMENT AGREEMENT ON
FLAVOCIDE
TECHNOLOGY
* AGREEMENT COVERS RIGHTS TO PROFESSIONAL PUBLIC HEALTH
MOSQUITO
CONTROL MARKET IN UNITED STATES AND CAYMAN ISLANDS
Further company coverage: BGT.AX
Recent news on Bio-Gene Technology
See all newsBrief: Bio-Gene Technology Receives Total Placement Commitments Of A$2.78 Million
Australia's Bio-Gene Technology slips to 4-1/2-month low on discounted placement
Brief: Bio-Gene Technology Ltd Raises A$3.21 MLN Via Placement, Partially Underwritten Share Purchase Plan
Brief: Bio-Gene Technology Seeks Trading Halt
Australia's Bio‑Gene surges on Asia expansion optimism for mosquito control products